Geneza Pharmaceuticals GP Prima 100
Geneza Pharmaceuticals GP Prima 100 is introduced in a 10-milliliter multidose vial and purportedly contains 100 milligrams of methenolone enanthate per milliliter as indicated by name as well as bundling. Tests of this item were bought from an European-based web source between the dates of August 1, 2016 and September 15, 2016. The examples were sent and gotten by the explanatory research facility SIMEC AG on September 29, 2016. SIMEC performed HPLC-UV quantitative measurement testing, ‘all out aerobial microbiological check’ (TAMC) testing and ‘all out yeast and form tally’ (TYMC) testing. The report was finished on November 17, 2016.
The “parcel number” recorded on the item was GP138CN and the termination date was March 2018. The ISN number “A4N6814M92DP” was effectively used to confirm the legitimacy of the item on genezapharmaceuticals.com. Mark guarantee: Geneza Pharmaceuticals GP Prima (100mg) has a name guarantee of 100 mg/ml methenolone enanthate. Genuine substance: Geneza Pharmaceuticals GP Prima 100 was resolved to have a real substance of 96.4 mg/ml methenolone enanthate.